Clinical Trial Update: Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing neoadjuvant versus adjuvant treatment for locally advanced recurrent nasopharyngeal carcinoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Recurrent Nasopharyngeal Carcinoma | Phase 3 | Status: RECRUITING